{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T02:12:01Z","timestamp":1768097521920,"version":"3.49.0"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:00:00Z","timestamp":1389225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1003409","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T21:18:02Z","timestamp":1389302282000},"page":"e1003409","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Induction of Wnt-Inducible Signaling Protein-1 Correlates with Invasive Breast Cancer Oncogenesis and Reduced Type 1 Cell-Mediated Cytotoxic Immunity: A Retrospective Study"],"prefix":"10.1371","volume":"10","author":[{"given":"David J.","family":"Klinke II","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses her2","volume":"344","author":"DJ Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"ref2","first-page":"122","article-title":"Breast cancer. Clinical practice guidelines in oncology","volume":"7","author":"RW Carlson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrc2713","article-title":"Biological determinants of endocrine resistance in breast cancer","volume":"9","author":"EA Musgrove","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1200\/JCO.2009.27.6360","article-title":"Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape","volume":"28","author":"RL Ferris","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fonc.2012.00202","article-title":"An evolutionary perspective on anti-tumor immunity","volume":"2","author":"DJ Klinke","year":"2013","journal-title":"Front Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nrc2013","article-title":"Cancer as an evolutionary and ecological process","volume":"6","author":"LM Merlo","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"M Greaves","year":"2012","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.887927","article-title":"Metastasis results from preexisting variant cells within a malignant tumor","volume":"197","author":"IJ Fidler","year":"1977","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","article-title":"The clonal and mutational evolution spectrum of primary triple-negative breast cancers","volume":"486","author":"SP Shah","year":"2012","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"C Curtis","year":"2012","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature11143","article-title":"Whole-genome analysis informs breast cancer response to aromatase inhibition","volume":"486","author":"MJ Ellis","year":"2012","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"PJ Stephens","year":"2012","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature11154","article-title":"Sequence analysis of mutations and translocations across breast cancer subtypes","volume":"486","author":"S Banerji","year":"2012","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"DC Koboldt","year":"2012","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.1069981","article-title":"Reverse engineering of biological complexity","volume":"295","author":"ME Csete","year":"2002","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20112738","article-title":"Cancer immunoediting by the innate immune system in the absence of adaptive immunity","volume":"209","author":"T O'Sullivan","year":"2012","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"G Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/338625","article-title":"Inherited interleukin-12 deficiency: Il12b genotype and clinical phenotype of 13 patients from six kindreds","volume":"70","author":"C Picard","year":"2002","journal-title":"Am J Hum Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.20021769","article-title":"Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications","volume":"197","author":"C Fieschi","year":"2003","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1182\/blood-2005-05-2034","article-title":"Lack of il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy","volume":"106","author":"I Airoldi","year":"2005","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1158\/1078-0432.CCR-04-0265","article-title":"A phase i study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients","volume":"10","author":"R Parihar","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(01)00032-6","article-title":"Interleukin-12 in anti-tumor immunity and immunotherapy","volume":"13","author":"MP Colombo","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-10-0735","article-title":"Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts","volume":"70","author":"SP Kerkar","year":"2010","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1182\/blood-2011-12-400044","article-title":"Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning","volume":"119","author":"HJ Pegram","year":"2012","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1101\/gad.14.5.585","article-title":"WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene","volume":"14","author":"L Xu","year":"2000","journal-title":"Genes Dev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1039\/c2ib20053h","article-title":"A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model","volume":"4","author":"YM Kulkarni","year":"2012","journal-title":"Integr Biol (Camb)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"A Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","article-title":"Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes","volume":"70","author":"K Movahedi","year":"2010","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper cd4+ t cells","volume":"327","author":"JJ O'Shea","year":"2010","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells","volume":"30","author":"G Wei","year":"2009","journal-title":"Immunity"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jtbi.2005.09.022","article-title":"The ratio of p40 monomer to dimer is an important determinant of il-12 bioactivity","volume":"240","author":"DJ Klinke","year":"2006","journal-title":"J Theor Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"JS Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10549-011-1412-7","article-title":"TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine \u00b1 trastuzumab","volume":"132","author":"S Gluck","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref35","first-page":"961753","article-title":"A Role for PPARgamma in the Regulation of Cytokines in Immune Cells and Cancer","volume":"2008","author":"XY Yang","year":"2008","journal-title":"PPAR Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/mol.64.5.1169","article-title":"Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor","volume":"64","author":"SW Chung","year":"2003","journal-title":"Mol Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.20021384","article-title":"Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation","volume":"198","author":"G Woerly","year":"2003","journal-title":"J Exp Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"ra32","DOI":"10.1126\/scisignal.2002657","article-title":"Quantifying crosstalk among interferon-\u03b3, interleukin-12, and tumor necrosis factor signaling pathways within a TH1 cell model","volume":"5","author":"DJ Klinke","year":"2012","journal-title":"Sci Signal"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1182\/blood-2006-09-045245","article-title":"Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response","volume":"109","author":"LX Wang","year":"2007","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjc.6605772","article-title":"Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma","volume":"103","author":"T Maruyama","year":"2010","journal-title":"Br J Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/0008-5472.CAN-2522-2","article-title":"HER-2\/neu-mediated regulation of components of the MHC class I antigen-processing pathway","volume":"64","author":"F Herrmann","year":"2004","journal-title":"Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2837","article-title":"Development of metastatic HER2(+) breast cancer is independent of the adaptive immune system","volume":"224","author":"M Ciampricotti","year":"2011","journal-title":"J Pathol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nm.2652","article-title":"Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system","volume":"18","author":"M Ciampricotti","year":"2012","journal-title":"Nat Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/scbi.1995.0018","article-title":"Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer","volume":"6","author":"F van Leeuwen","year":"1995","journal-title":"Semin Cancer Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature10803","article-title":"Expression of tumour-specific antigens underlies cancer immunoediting","volume":"482","author":"M DuPage","year":"2012","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/gb-2007-8-5-r76","article-title":"Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors","volume":"8","author":"JI Herschkowitz","year":"2007","journal-title":"Genome Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"J Seok","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref48","first-page":"481","article-title":"Animal models of cancer immunotherapy: questions of relevance","volume":"64","author":"DW Weiss","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.CCR-11-2701","article-title":"Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer","volume":"19","author":"F Andre","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1200\/JCO.2011.39.5624","article-title":"Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis","volume":"30","author":"M Ignatiadis","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1186\/gb-2007-8-8-r157","article-title":"An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer","volume":"8","author":"AE Teschendorff","year":"2007","journal-title":"Genome Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"BD Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/1078-0432.CCR-07-4756","article-title":"Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes","volume":"14","author":"C Desmedt","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jnci\/djq524","article-title":"Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer","volume":"103","author":"T Iwamoto","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1764","article-title":"Stromal gene expression predicts clinical outcome in breast cancer","volume":"14","author":"G Finak","year":"2008","journal-title":"Nat Med"},{"key":"ref56","first-page":"8917","article-title":"Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features","volume":"61","author":"D Xie","year":"2001","journal-title":"Cancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1245\/s10434-007-9376-x","article-title":"Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer","volume":"14","author":"SR Davies","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"ref58","first-page":"795","article-title":"The ccn proteins: important signaling mediators in stem cell differentiation and tumorigenesis","volume":"25","author":"GW Zuo","year":"2010","journal-title":"Histol Histopathol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of e-cadherin promotes metastasis via multiple downstream transcriptional pathways","volume":"68","author":"T Onder","year":"2008","journal-title":"Cancer Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/jcb.21754","article-title":"TGF-beta1 and WISP-1\/CCN-4 can regulate each other&apos;s activity to cooperatively control osteoblast function","volume":"104","author":"CA Inkson","year":"2008","journal-title":"J Cell Biochem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jbmr.205","article-title":"WISP-1\/CCN4 regulates osteogenesis by enhancing BMP-2 activity","volume":"26","author":"M Ono","year":"2011","journal-title":"J Bone Miner Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jcp.21943","article-title":"GATA3 in development and cancer differentiation: cells GATA have it!","volume":"222","author":"J Chou","year":"2010","journal-title":"J Cell Physiol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri2476","article-title":"GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation","volume":"9","author":"IC Ho","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based Human Protein Atlas","volume":"28","author":"M Uhlen","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A human protein atlas for normal and cancer tissues based on antibody proteomics","volume":"4","author":"M Uhlen","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"ref66","first-page":"291","article-title":"Quantification of histochemical staining by color deconvolution","volume":"23","author":"AC Ruifrok","year":"2001","journal-title":"Anal Quant Cytol Histol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/biomet\/52.3-4.355","article-title":"The bayesian estimation of common parameters from several responses","volume":"52","author":"GEP Box","year":"1965","journal-title":"Biometrika"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1098\/rsif.2008.0172","article-title":"Approximate bayesian computation scheme for parameter inference and model selection in dynamical systems","volume":"6","author":"T Toni","year":"2009","journal-title":"Journal of the Royal Society Interface"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1214\/ss\/1177013815","article-title":"Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy","volume":"1","author":"B Efron","year":"1986","journal-title":"Stat Science"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"e1002240","DOI":"10.1371\/journal.pcbi.1002240","article-title":"Most random gene expression signatures are significantly associated with breast cancer outcome","volume":"7","author":"D Venet","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1741-7015-10-51","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration","volume":"10","author":"DG Altman","year":"2012","journal-title":"BMC Med"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-5956-10-11","article-title":"Protein-based identification of quantitative trait loci associated with malignant transformation in two HER2+ cellular models of breast cancer","volume":"10","author":"YM Kulkarni","year":"2012","journal-title":"Proteome Sci"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cyto.a.20746","article-title":"Scalable analysis of flow cytometry data using r\/bioconductor","volume":"75","author":"DJ Klinke","year":"2009","journal-title":"Cytometry A"},{"key":"ref74","unstructured":"BioCarta (Accessed 08\/20\/2012) Biocarta pathways. In: BioCarta Pathways, <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.biocarta.com\" xlink:type=\"simple\">www.biocarta.com<\/ext-link>."},{"key":"ref75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"AE Karnoub","year":"2007","journal-title":"Nature"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"GP Sims","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm0902-1039c","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"H Dong","year":"2002","journal-title":"Nat Med"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1593\/neo.05733","article-title":"The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors","volume":"8","author":"H Ghebeh","year":"2006","journal-title":"Neoplasia"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"JR Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","article-title":"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression","volume":"70","author":"AL Doedens","year":"2010","journal-title":"Cancer Res"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology Meets Immunology: The Cancer-Immunity Cycle","volume":"39","author":"DS Chen","year":"2013","journal-title":"Immunity"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1003409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T22:07:10Z","timestamp":1647986830000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1003409"}},"subtitle":[],"editor":[{"given":"Stanislav","family":"Shvartsman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1003409","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]}}}